Keith E. Davis

Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy.

S. Denardo, J. Tcheng, Keith E. Davis, 2005, American heart journal.

Pursuit of the Optimal Antithrombotic Regimen for Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Who Undergo Subsequent Percutaneous Coronary Intervention.

S. Denardo, J. Tcheng, Keith E. Davis, 2019, The American journal of cardiology.

Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.

S. Denardo, J. Tcheng, Keith E. Davis, 2007, The American journal of cardiology.

Dose-response effects of secobarbital on human memory

W. O. Evans, Keith E. Davis, 2004, Psychopharmacologia.

Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention.

S. Denardo, J. Tcheng, P. R. Reid, 2003, The American journal of cardiology.

REPRINT OF: Physical and Mental Health Effects of Intimate Partner Violence for Men and Women

H. Brandt, A. Coker, P. Smith, 2021, American Journal of Preventive Medicine.